DGAP-News
Biotest AG: Biotest AG opens sixth plasma collection centre in Hungary
DGAP-News: Biotest AG / Key word(s): Miscellaneous / |
PRESS RELEASE
Biotest AG opens sixth plasma collection centre in Hungary
- 14 plasma collection centres in Europe and
- 22 in the US to ensure long-term plasma supply
Dreieich, 19 April 2017. Biotest received an operating permit for its sixth plasma collection centre in Hungary from the country's national public health authority OTH. The centre is in the
western Hungarian city of Székesfehérvár and belongs to Europe's most modern ones. It provides space for up to 28 donation chairs. Thus, the company is further expanding its plasma collection
capacity and is adjusting the plasma supply to future growth.
The first plasma collection centre in Budapest was opened in 2009 by Plazmaszolgálat Kft., a 100% subsidiary of Biotest AG. "We are very pleased about the opening of another donor centre in Hungary. Our plasma collection organisation enables us to deliver highly ethical pharmaceutical products to the Hungarian market out of Hungarian plasma", stated Dr Martin Reinecke, Senior Vice President Plasma Alliances and Protein Supply of Biotest AG.
The collected plasma is processed only by Biotest AG in Dreieich. Regular audits in Hungary ensure that the strict legal and internal quality requirements are met.
About human blood plasma
Human blood plasma is a raw material used to produce plasma derived products, which are used to treat various illnesses of the immune system, the blood system, as well as in emergency medicine.
Biotest ranks as one of the world's sixth largest plasma protein product manufacturing groups. Biotest is one of the world's six largest manufacturers of plasma protein products.